Polycystic ovary syndrome

Polycystic Ovary Syndrome (PCOS) By Navodita Maurice | Submitted On September 01, 2011 Recommend Article Article Comments Print Article Share this article on Facebook Share this article on Twitter Share this article on Google+ Share this article on Linkedin Share this article on StumbleUpon 1 Share this article on Delicious Share this article on Digg Share this article on Reddit Share this article on Pinterest Expert Author Navodita Maurice The endocrine disorders among females are of various

Women in group II include those with polycystic ovary syndrome and hyperprolactinemia. Women in group III can conceive only with oocyte donation and in vitro fertilization.(10) Terminology in reproductive medicine is indeed confusing and misleading (11). Another term Subfertility is described as any

Polycystic Ovary Syndrome (PCOS) is a common hormonal disorder among women of reproductive age and is caused by an imbalance of a woman's female sex hormones, resulting in higher levels of the male hormone, androgen and have irregular periods. The ovaries may develop numerous small collections of fluid (follicles) and fail to regularly release eggs. This makes it difficult for women to get pregnant. The presence of androgen may result in physical signs, such as excess facial and body hair (hirsutism)

 Polycystic Ovary Syndrome Dr. Sqouras Christal Alfonso Burhan Sadiq In this research paper I will attempt to discuss the causes, symptoms and signs of Polycystic Ovarian Syndrome, as well as how it is diagnosed and treated. As someone who is suffering from this disease, I found my research to be very informative and educational, raising awareness for my own understanding, and it is my intention to ensure that this same awareness is translated in my research paper. What is Polycystic Ovarian

Polycystic Ovarian Syndrome When it comes to the reproductive system there are a book full, from A to Z of diseases that affect both men and women. Some genetically inherited, and others that are sexual transmitted, and of course those that are so rare you can see the name of them and ask yourself, “Wait, what?” because of the more then difficult spelling of the names of the disease and the areas that the diseases affect or their symptoms, they can be quite a shock to some. Now, there are a few

recent years that effects women’s health is Polycystic Ovarian Syndrome (PCOS). For more women to become knowledgeable about this disease health professionals need to educate women about what PCOS is, we need to recognize what ecological factors play a role in PCOS, and what can be done to help women manage their PCOS disease. Polycystic Ovarian Syndrome Approximately, eight to twenty percent of women worldwide suffer from Polycystic Ovarian Syndrome worldwide (National Institute of child health

low grade inflammation, however despite the risk factors clustering, studies have not been able to correlate a uniform association between PCOS and cardiovascular disease (Pasquali et al., 2011). Oxidative stress can also be present in non-obese PCOS patients. Cardiovascular disease is increased by PCOS, therapies for this particular symptom could include the use of antioxidants as a corrective measure, to improve the effects of oxidative stress by reducing insulin resistance and hyperandrogenism

PCOS is also known as polycystic ovarian syndrome. It is the most common en- docrine disorder of females. The rate of being diagnosed with this disorder is be- tween 5-10 percent. It is a disorder in which there are an abnormal number of hor- mones in the body. It affects the entire body to some degree. Its origins are unclear but it is believed to be related to insulin resistance or what is sometimes called “in- sulin insensitivity syndrome.” Once thought to be a disease of thirty some year

Even if the percentage for hormonal and gonadal abnormalities is more compared to chromosomal abnormalities in SA, cytogenetic investigation is a must. The percentage of total CA (16%) in SA of the present study will hold good with previous studies which vary from 5 – 33.3% and pure numerical abnormalities (45,X; 47,XXX) could not be observed (table 3). The CA observed was only X mosaicism in two of the studies (gupta, Butnarui) as compared to present study (16/43%). The percentage for X mosaicism

from ovarian hyperandrogenism, hyperinsulinemia secondary to insulin resistance and altered intraovarian paracrine signalling, which disrupt the growth of ovarian follicles. Arrested follicular development results in menstrual irregularity, polycystic ovaries, further hyperinsulinaemia and excess androgen production2,7. Anovulation is the predominant cause of infertility in PCOS8, with fewer women experiencing impaired oocyte development resulting in miscarriages9. The optimal treatment for infertile